Clinical Trial Update: TAXUS Libertē Post Approval Study

View source ↗

Summary

Completion of the TAXUS Liberté Post Approval Study evaluating the TAXUS Liberté paclitaxel-eluting stent in patients with coronary artery disease; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TAXUS Liberté paclitaxel-eluting stent (paclitaxel-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Status: COMPLETED | Results posted: 2015-04-13